Zirconium-89-labelled rituximab PET-CT in orbital inflammatory disease

por Laban, Kamil G., Kalmann, Rachel, Leguit, Roos J., de Keizer, Bart
Publicado 2019

CCN2 (Cellular Communication Network factor 2) in the bone marrow microenvironment, normal and malignant hematopoiesis

por Leguit, Roos J., Raymakers, Reinier A. P., Hebeda, Konnie M., Goldschmeding, Roel
Publicado 2021

First Report of IgG4 Related Disease Primary Presenting as Vertebral Bone Marrow Lesions

por van den Elshout-den Uyl, Debby, Spoto, Clothaire P. E., de Boer, Mirthe, Leiner, Tim, Leavis, Helen L., Leguit, Roos J.
Publicado 2019

Severe outcome of idiopathic inflammatory mass lesions primarily located in the posterior orbit and orbital apex

por Laban, Kamil G., Kalmann, Rachel, Leguit, Roos J., Uijttewaal, Peter H., Radstake, Timothy R.D.J., de Boer, Joke H., van der Veen, Rob L.P.
Publicado 2020

Hematologic malignancies following immune checkpoint inhibition for solid tumors

por van Eijs, Mick J. M., van der Wagen, Lotte E., Mous, Rogier, Leguit, Roos J., van de Corput, Lisette, van Lindert, Anne S. R., Suelmann, Britt B. M., Kamphuis, Anna M., Nierkens, Stefan, Suijkerbuijk, Karijn P. M.
Publicado 2022